Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Kymab initiates phase II study of KY-1005 in atopic dermatitis

Jan. 9, 2019

Promising phase II data presented for AK-002 in Xolair-naive chronic spontaneous urticaria patients

Jan. 8, 2019

Boehringer Ingelheim patents VNN1 inhibitors

Jan. 3, 2019

Epigenetic protein switches function after development

Jan. 3, 2019

Life Science Institute initiates exploratory clinical trial of CL-2020 in epidermolysis bullosa

Dec. 24, 2018

FDA grants permission to initiate first-in-human study of ASN-008

Dec. 21, 2018

Repigmentation therapy with Scenesse and NB-UVB effective in vitiligo

Dec. 19, 2018

Corbus initiates phase III DETERMINE study based on phase II data in dermatomyositis

Dec. 19, 2018

Pyramid Biosciences licenses TRK modulator from AstraZeneca

Dec. 19, 2018

Aclaris offers update on clinical trials of JAK1/3 inhibitors ATI-502 and ATI-501

Dec. 18, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 16, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...